Global Bipolar Disorder Treatment Market Size to Grow at a CAGR of 2.5% in the Forecast Period of 2023-2031

The ‘Global Bipolar Disorder Treatment Market Size, Share, Analysis, Growth, Report and Forecast 2023-2031’ by Expert Market Research provides an extensive outlook of the global bipolar disorder treatment market, assessing the market based on its segments like drug type, distribution channel, and major regions. The report also offers a detailed insight of the market on the basis of patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnership and collaborations analysis.

Bipolar Disorder Treatment Size, Share, Trends, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

• Historical Market Size (2022): USD 5.3 Billion

• Forecast CAGR (2023-2031): 2.5%

• Forecast Market Size (2031): USD 6.7 Billion

The growth of the global bipolar disorder treatment market is driven by the increasing awareness of mental health disorders, advancements in diagnostic techniques, and the development of new medications. However, the social stigma associated with mental health disorders and inadequate healthcare infrastructure in some regions may hinder the market growth.

The growing demand for personalized medicine and the increasing number of clinical trials for the development of novel treatment options are expected to create lucrative growth opportunities for the bipolar disorder treatment market. Additionally, government initiatives and public-private partnerships to improve mental healthcare infrastructure are likely to contribute to the market growth.

Get a Free Sample Report with Table of Contents@

Bipolar Disorder Treatment Industry Definition and Major Segments

Bipolar disorder, also known as manic-depressive illness, is a mental health condition characterized by unusual shifts in mood, energy, activity levels, and the ability to carry out daily tasks. Treatment options include medication, psychotherapy, and lifestyle changes.

Based on type, the market is segmented into:

• Bipolar I Disorder
• Bipolar II Disorder
• Cyclothymic Disorder

Based on mechanism of action, the market is segmented into:

• Tricyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Benzodiazepines
• Serotonin-Norepinephrine Reuptake Inhibitors
• Beta-Blockers
• Selective Serotonin Reuptake Inhibitors
• Others

Based on diagnosis methods, the market is classified into:

• Physical Exam
• Psychiatric Assessment
• Mood Charting

Based on treatment type, the market is segregated into:

• Non-Pharmaceuticals

    • Acupuncture
    • Bright Light Therapy
    • Exercise Therapy
    • Sleep Deprivation
    • Vagus Nerve Stimulation

• Pharmaceuticals

    • Mood Stabilizers
    • Antidepressants
    • Antipsychotics
    • Adjunctive and Alternative Treatments

• Psychotherapy

    • Cognitive Behavioural Therapy
    • Group Therapy
    • Interpersonal and Social Rhythm Therapy
    • Vocational Therapy

Based on treatment type, the market is segregated into:

• Public
• Private

Based on region, the market is segregated into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Bipolar Disorder Treatment Market Trends

The key trends in the global bipolar disorder treatment market include the development of new drug combinations and targeted therapies to combat the disorder. The increasing prevalence of bipolar disorder and the growing demand for personalized medicine are also expected to drive the market growth.
Advancements in diagnostic techniques, such as neuroimaging and genetic testing, have improved the early diagnosis and treatment of bipolar disorder. The increasing adoption of telepsychiatry and digital therapeutics is expected to further boost the market growth. The growing emphasis on mental health awareness campaigns and the development of innovative treatment options, such as neuromodulation techniques, are likely to contribute to the market growth.

Key Market Players

The major players in the global bipolar disorder treatment market report are Takeda Pharmaceutical Industries Ltd., AstraZeneca, GlaxoSmithKline, Eli Lilly and Company, Johnson & Johnson Services, Inc., Allergan, AbbVie Inc., and Pfizer Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

The report studies the latest updates in the market, along with their impact across the market. It also analyzes the market demand, together with its price and demand indicators. The report also tracks the market based on SWOT and Porter’s Five Forces Models.

Thanks for allowing guest posting